The Estée Lauder Companies, in collaboration with the Breast Cancer Research Foundation (BCRF), has launched a significant new initiative aimed at improving research into early-onset breast cancer. This initiative, which promises a generous investment of £15 million over the next five years, aims to shine a light on the unique challenges faced by younger women diagnosed with this disease.
:max_bytes(150000):strip_icc():format(jpeg)/elizabeth-hurley-estee-lauder-1-5a2eaa88aecb450086698dbc303bea25.jpg)
Elizabeth Hurley, who serves as the global ambassador for The Estée Lauder Companies’ Breast Cancer Campaign, emphasised the pressing need for better detection and treatment options during a recent interview. She noted that while awareness has grown significantly since she began her advocacy work in 1995, many vital issues remain unresolved. The rise in breast cancer cases among younger women is particularly alarming. Hurley explained that unlike in the past, where treatments were more generic, the focus now is on understanding the biology of different breast cancers, including those that affect a younger demographic.

According to the latest statistics from BCRF, there has been an 11 per cent rise in diagnoses among women under 45 in the decade leading up to 2022. However, this group has received a meagre 0.6 per cent of breast cancer research funding since 2020. Younger women often encounter particularly aggressive forms of the disease, leading to diagnoses at later stages when prognosis can be grim. Hurley expressed her personal connection to this issue, having met young survivors whose accounts brought the matter into sharper focus for her.

Bridget Bahl, a breast cancer survivor and founder of The Bar, shared her own story to highlight the urgency of early detection. Bahl recalled how, during her IVF treatment, she noticed changes in her breast, but initially dismissed them as side effects of hormones. The subsequent diagnosis of an aggressive, fast-growing tumour intensified her awareness of how crucial it is for younger women to seek help immediately.
Bahl’s experience underscores a common misconception that breast cancer predominantly targets older women. She noted the risk of younger individuals ignoring changes in their bodies due to the belief that they are not at risk. Initially reluctant to become an advocate herself, Bahl found herself driven by the supportive messages she received from others who acted on her experiences.
Her treatment journey was challenging, and she expressed the importance of early detection not just for survival but to potentially avoid arduous treatment processes like chemotherapy. Having completed her treatment in May, Bahl is now eager to share her journey and knowledge, emphasising a renewed appreciation for life’s everyday activities.
Research has progressed dramatically since Bahl’s diagnosis, with medicines like Herceptin and Perjeta offering targeted therapies for specific types of breast cancer. Both Bahl and Hurley believe that sustained funding for research is imperative for continued advancements in patient care.
The campaign to promote breast health does not stop at research; it extends to empowering women to take charge of their own health. Hurley referenced the foundational teachings of Evelyn H. Lauder, who encouraged women to perform regular self-examinations and to be aware of their bodies. She reiterated the importance of finding a routine that works for each individual, suggesting that familiarity with one’s own body is vital in recognising changes.
Bahl added that the most crucial aspect of self-examinations isn’t identifying specific symptoms but rather detecting any changes. Many women feel uncertain about what to look for, often leading to hesitation in seeking medical advice. Therefore, making discussions surrounding breast health more approachable is essential for encouraging proactive healthcare decisions.
As part of the awareness efforts, the Empire State Building was lit in pink on October 1 as a symbol of solidarity in the fight against breast cancer. Hurley, alongside Bahl and other advocates, participated in a lighting ceremony that illuminated one of New York’s iconic landmarks with a strong message of hope and vigilance.
The new Global Research Initiative on Breast Cancer in Younger Women serves as the next pivotal step in transforming the landscape of research and care, directing attention towards a population that has often been ignored. As Hurley aptly put it, “Any change should be reported.” This encapsulates the essence of the ongoing campaign: while scientific advancements are crucial, the importance of awareness and early intervention cannot be overstated.
Through initiatives like this, The Estée Lauder Companies and the BCRF are not only advocating for change; they are creating a future where younger women are equipped with the knowledge and resources needed to address breast cancer with urgency and confidence.
